Literature DB >> 10810625

Development of clinical trial of E1A gene therapy targeting HER-2/neu-overexpressing breast and ovarian cancer.

M C Hung1, G N Hortobagyi, N T Ueno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10810625     DOI： 10.1007/0-306-46817-4_16

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  16 in total

1.  Downregulation of microRNA miR-520h by E1A contributes to anticancer activity.

Authors:  Jen-Liang Su; Poshen B Chen; Ya-Huey Chen; Shang-Chih Chen; Yi-Wen Chang; Yi-Hua Jan; Xiaoyun Cheng; Michael Hsiao; Mien-Chie Hung
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

2.  Breast Cancer Treatment in the Era of Molecular Imaging.

Authors:  Gundula Edelhauser; Martin Funovics
Journal:  Breast Care (Basel)       Date:  2008-12-17       Impact factor: 2.860

Review 3.  Gene therapy for carcinoma of the breast.

Authors:  M A Stoff-Khalili; P Dall; D T Curiel
Journal:  Cancer Gene Ther       Date:  2006-01-06       Impact factor: 5.987

4.  FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization.

Authors:  Jen-Liang Su; Xiaoyun Cheng; Hirohito Yamaguchi; Yi-Wen Chang; Chao-Feng Hou; Dung-Fang Lee; How-Wen Ko; Kuo-Tai Hua; Ying-Nai Wang; Michael Hsiao; Poshen B Chen; Jung-Mao Hsu; Robert C Bast; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Cancer Res       Date:  2011-09-12       Impact factor: 12.701

5.  Adenovirus 5 E1A enhances histone deacetylase inhibitors-induced apoptosis through Egr-1-mediated Bim upregulation.

Authors:  H Yamaguchi; C-T Chen; C-K Chou; A Pal; W Bornmann; G N Hortobagyi; M-C Hung
Journal:  Oncogene       Date:  2010-08-02       Impact factor: 9.867

Review 6.  Second-line and subsequent therapy for ovarian carcinoma.

Authors:  Prema P Peethambaram; Harry J Long
Journal:  Curr Oncol Rep       Date:  2002-03       Impact factor: 5.075

7.  Regulation of the activity of p38 mitogen-activated protein kinase by Akt in cancer and adenoviral protein E1A-mediated sensitization to apoptosis.

Authors:  Yong Liao; Mien-Chie Hung
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer.

Authors:  M A Trujillo; M J Oneal; S McDonough; R Qin; J C Morris
Journal:  Gene Ther       Date:  2010-04-29       Impact factor: 5.250

9.  E1a promotes c-Myc-dependent replicative stress: implications in glioblastoma radiosensitization.

Authors:  María Llanos Valero; Francisco Jose Cimas; Laura Arias; Pedro Melgar-Rojas; Elena García; Juan Luis Callejas-Valera; Jesús García-Cano; Leticia Serrano-Oviedo; Miguel Ángel de la Cruz-Morcillo; Isabel Sánchez-Pérez; Ricardo Sánchez-Prieto
Journal:  Cell Cycle       Date:  2013-10-11       Impact factor: 4.534

10.  Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer.

Authors:  Miguel A Trujillo; Michael J Oneal; Julia Davydova; Elizabeth Bergert; Masato Yamamoto; John C Morris
Journal:  Breast Cancer Res       Date:  2009-07-27       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.